The author, a known pharma expert, strongly defends the legitimacy and highlights the significant late-stage (Phase 3) trial status of Eli Lilly's drug Retatrutide, implying a bullish outlook on its prospects.
LLY
MED
Mar 17, 17:22
"retatrutide is literally a biopharmaceutical from Eli Lilly - pirating the better ozempic it is not what we're talking about here and it's PHASE three jesus christ"
March 17, 2026 at 17:22